UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The treatment of melanoma at Westminster Hospital in the 20th century

Journal of B.U. ON., 2013-04, Vol.18 (2), p.537-543

Retsas, S

2013

Volltextzugriff (PDF)

Progress but not enough: the 2009 (7th) revision of the American Joint Committee on Cancer (AJCC) for melanoma staging and classification

Journal of B.U. ON., 2011-01, Vol.16 (1), p.38

Retsas, S

2011

Volltextzugriff (PDF)

Aristotle and Darwin. Parallel lives

Journal of B.U. ON., 2009-04, Vol.14 (2), p.333

Retsas, S

2009

Volltextzugriff (PDF)

Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): validation in a cohort of 1284 patients

European journal of cancer (1990), 2002-03, Vol.38 (4), p.511-516

2002

Volltextzugriff (PDF)

Systemic treatment of melanoma: quo vadis oncologist?

Journal of B.U. ON., 2007-01, Vol.12 (1), p.29

Retsas, S

2007

Volltextzugriff (PDF)

In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell lines

European journal of cancer (1990), 1997-03, Vol.33 (3), p.463-470

1997

Volltextzugriff (PDF)

Melanoma involving the gastrointestinal tract

Anticancer research, 2001-03, Vol.21 (2B), p.1503

2001

Volltextzugriff (PDF)

Adjuvant therapy of melanoma

The Lancet (British edition), 1998-08, Vol.352 (9129), p.737-738

Retsas, Spyros

1998

Volltextzugriff (PDF)

Prognostic factors in therapeutic lymphadenectomy in melanoma

Melanoma research, 2001-06, Vol.11 (3), p.315

Retsas, S

2001

Volltextzugriff (PDF)

In Vitro Cytotoxicity of Norviburtinal and Isopinnatal from Kigelia pinnata Against Cancer Cell Lines

Planta medica, 2000-12, Vol.66 (8), p.758-761

2000

Volltextzugriff (PDF)

What is the Optimal Therapy of Brain Metastases?

Clinical oncology (Royal College of Radiologists (Great Britain)), 2001-04, Vol.13 (2), p.105-111

2001

Volltextzugriff (PDF)

Sentinel node biopsy confers no added protection to patients with melanoma

Journal of the Royal Society of Medicine, 2007-08, Vol.100 (8), p.391-392

Retsas, S.

2007

Volltextzugriff (PDF)

Overexpression of HER-2 in thick melanoma

Melanoma research, 2002-04, Vol.12 (2), p.139-145

2002

Volltextzugriff (PDF)

Report on the 4th International Conference on the Adjuvant Therapy of Malignant Melanoma held at the Royal College of Physicians, London, UK, 15-16 March 2002

Melanoma research, 2002-06, Vol.12 (3), p.A1-A4

2002

Volltextzugriff (PDF)

The CDKN2A tumour suppressor gene: no mutations detected in patients with melanoma and additional unrelated cancers

Melanoma research, 2002-12, Vol.12 (6), p.559-563

2002

Volltextzugriff (PDF)

Activity of extracts of Kigelia pinnata against melanoma and renal carcinoma cell lines

Planta medica, 1994-10, Vol.60 (5), p.430-433

1994

Volltextzugriff (PDF)

11 Hypothesis: are viruses involved in the induction and progression of melanoma?

Melanoma research, 2004-08, Vol.14 (4), p.A6-A7

Retsas, S.

2004

Volltextzugriff (PDF)

Report on the 5th International Conference on the Adjuvant Therapy of Malignant Melanoma held in Athens, Greece, 18–20 March, 2004

Melanoma research, 2004-08, Vol.14 (4), p.A1-A2

Retsas, S.

2004

Volltextzugriff (PDF)

12 Systemic treatment of metastatic melanoma: current options

Melanoma research, 2004-08, Vol.14 (4), p.A7

Retsas, S.

2004

Volltextzugriff (PDF)

Melanoma and additional primary cancers

Melanoma research, 2000-04, Vol.10 (2), p.145-152

2000

Volltextzugriff (PDF)

Systemic Treatments For Metastatic Melanoma

Melanoma research, 2004-04, Vol.14 (2), p.S23

Retsas, S.

2004

Volltextzugriff (PDF)

Adjuvant therapy of malignant melanoma: is there a choice?

Critical reviews in oncology/hematology, 2001-11, Vol.40 (2), p.187-193

Retsas, Spyros

2001

Volltextzugriff (PDF)

Detection of tyrosinase mRNA by RT-PCR in the peripheral blood of patients with advanced metastatic melanoma

Melanoma research, 1999-08, Vol.9 (4), p.395-400

1999

Volltextzugriff (PDF)

Treatment at random: The ultimate science or the betrayal of hippocrates?

Journal of clinical oncology, 2004-12, Vol.22 (24), p.5005-5011

2004

Volltextzugriff (PDF)

EARLY OR LOW-GRADE MELANOMA?

The Lancet (British edition), 1987-08, Vol.330 (8553), p.276-277

Retsas, S.

1987

Volltextzugriff (PDF)

1 – 25 von 201

Menü

Weitere Dienste

Einstellungen

The treatment of melanoma at Westminster Hospital in the 20th century

Progress but not enough: the 2009 (7th) revision of the American Joint Committee on Cancer (AJCC) for melanoma staging and classification

Aristotle and Darwin. Parallel lives

Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): validation in a cohort of 1284 patients

Systemic treatment of melanoma: quo vadis oncologist?

In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell lines

Melanoma involving the gastrointestinal tract

Adjuvant therapy of melanoma

Prognostic factors in therapeutic lymphadenectomy in melanoma

In Vitro Cytotoxicity of Norviburtinal and Isopinnatal from Kigelia pinnata Against Cancer Cell Lines

What is the Optimal Therapy of Brain Metastases?

Sentinel node biopsy confers no added protection to patients with melanoma

Overexpression of HER-2 in thick melanoma

Report on the 4th International Conference on the Adjuvant Therapy of Malignant Melanoma held at the Royal College of Physicians, London, UK, 15-16 March 2002

The CDKN2A tumour suppressor gene: no mutations detected in patients with melanoma and additional unrelated cancers

Activity of extracts of Kigelia pinnata against melanoma and renal carcinoma cell lines

11 Hypothesis: are viruses involved in the induction and progression of melanoma?

Report on the 5th International Conference on the Adjuvant Therapy of Malignant Melanoma held in Athens, Greece, 18–20 March, 2004

12 Systemic treatment of metastatic melanoma: current options

Melanoma and additional primary cancers

Systemic Treatments For Metastatic Melanoma

Adjuvant therapy of malignant melanoma: is there a choice?

Detection of tyrosinase mRNA by RT-PCR in the peripheral blood of patients with advanced metastatic melanoma

Treatment at random: The ultimate science or the betrayal of hippocrates?

EARLY OR LOW-GRADE MELANOMA?

Suchergebnisse filtern